1. Home
  2. AGYS vs VERA Comparison

AGYS vs VERA Comparison

Compare AGYS & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Agilysys Inc.

AGYS

Agilysys Inc.

SELL

Current Price

$100.63

Market Cap

3.1B

Sector

Technology

ML Signal

SELL

Logo Vera Therapeutics Inc.

VERA

Vera Therapeutics Inc.

HOLD

Current Price

$29.76

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGYS
VERA
Founded
1963
2016
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
3.0B
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
AGYS
VERA
Price
$100.63
$29.76
Analyst Decision
Buy
Strong Buy
Analyst Count
8
14
Target Price
★ $134.50
$77.50
AVG Volume (30 Days)
181.0K
★ 2.2M
Earning Date
10-26-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 67.07
N/A
EPS
★ 0.32
N/A
Revenue
★ $319,312,000.00
N/A
Revenue This Year
$16.13
N/A
Revenue Next Year
$16.93
$792.38
P/E Ratio
$313.47
★ N/A
Revenue Growth
★ 15.85
N/A
52 Week Low
$61.50
$23.05
52 Week High
$144.82
$56.05

Technical Indicators

Market Signals
Indicator
AGYS
VERA
Relative Strength Index (RSI) 43.45 36.29
Support Level $94.74 N/A
Resistance Level $114.23 $36.95
Average True Range (ATR) 3.60 2.09
MACD -0.16 -0.41
Stochastic Oscillator 46.43 11.38

Price Performance

Historical Comparison
AGYS
VERA

About AGYS Agilysys Inc.

Agilysys Inc is engaged in hospitality software, delivering cloud-native SaaS and on-premise solutions for hotels, multi-amenity resorts, cruise lines, casinos, corporate foodservice management, restaurants, universities, stadiums, and healthcare facilities. The Company's software solutions include point-of-sale (POS), property management (PMS), inventory and procurement, payments, and related applications that manage and enhance the entire guest journey. It operates across the Americas, Europe, the Middle East, Africa, Asia-Pacific, and India with headquarters located in Alpharetta, GA. The Company has one reportable segment serving the global hospitality industry.

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Share on Social Networks: